Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes
Abdul-Ghani M, Maffei P, DeFronzo RA.
Lancet Diabetes Endocrinol. 2024 Aug 1:S2213-8587(24)00127-X. 
doi: 10.1016/S2213-8587(24)00127-X

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 
Phillip M, Achenbach P, Addala A et al.
Diabetes. Diabetes Care. 2024.
doi:10.2337/dci24-004

Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment
Richard I G Holt, Clive S Cockram, Ronald C W Ma , Andrea O Y Luk
Diabetologia. 2024 Jul;67(7):1168-1180.
doi: 10.1007/s00125-024-06102-x

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Vlado Perkovic, Katherine R Tuttle, Peter Rossing, et al,N Engl J Med. 2024 May 24. 
doi: 10.1056/NEJMoa2403347

Atypical Diabetes: What Have We Learned and What Does the Future Hold?
Stephen I Stone, Ashok Balasubramanyam, Jennifer E Posey 
Diabetes Care. 2024 May 1;47(5):770-781. 
doi.org/10.2337/dci23-0038